The Study of Polycystic Ovary Syndrome(PCOS) With Gene and Questionnaire
This study has been completed.
Information provided by (Responsible Party):
Ming-I Hsu, MD, Taipei Medical University WanFang Hospital
First received: April 29, 2010
Last updated: December 30, 2013
Last verified: December 2013
Polycystic ovary syndrome (PCOS) is an extremely common disorder in women of reproductive age. Diagnosis of PCOS is principally based on clinical and physical findings. Diagnostic criteria and PCOS definitions used by clinicians and researchers are almost as heterogeneous as the syndrome. This first part of study is determine whether genetic polymorphisms influence hormonal and metabolic characteristics in Taiwanese patients with PCOS and controls. Furthermore, women with PCOS were reported with high risk of cardiovascular disease, the investigators planned to calculate the difference of carotid intima-media thickness (IMT) and B-type natriuretic peptide (BNP) between women with PCOS and normal control to determine the premature atherosclerosis of women with PCOS.
Polycystic Ovary Syndrome
||Observational Model: Cohort
Time Perspective: Prospective
||The Study of Metabolic and Cardiac Vascular Risk in Patients With Polycystic Ovary Syndrome
Primary Outcome Measures:
- The correlation of PCOS betwwen metabolic and cardiovascular disease. [ Time Frame: Participant were followed for 1 month in study period. ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||August 2010 (Final data collection date for primary outcome measure)
Women with PCOS
|Ages Eligible for Study:
||15 Years to 45 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Polycystic Ovary Syndrome(PCOS)
- women at reproductive age
- women with PCOS and women without PCOS.
- young women who had their menarche less than 3 years
- women older than 45 years old, Amenorrhea of menopause, hyperglycemia, hyperthyroidism, hypothyroidism, heart failure, lung failure, renal failure, anemia, dystrophy, gonitis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01114659
|Taipei Medical University WanFang Hospital
|Taipei, Taiwan, 116 |
Taipei Medical University WanFang Hospital
||Ming-I Hsu, MD
||Wan Fang Hospital
No publications provided
||Ming-I Hsu, MD, Attending Doctor, Taipei Medical University WanFang Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||April 29, 2010
||December 30, 2013
||Taiwan: Department of Health
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on June 30, 2015
Polycystic Ovary Syndrome
Endocrine System Diseases
Genital Diseases, Female